Lymph node metastasis in early invasive lung adenocarcinoma: Prediction model establishment and validation based on genomic profiling and clinicopathologic characteristics

Wei Guo,Tong Lu,Yang Song,Anqi Li,Xijia Feng,Dingpei Han,Yuqin Cao,Debin Sun,Xiaoli Gong,Chengqiang Li,Runsen Jin,Hailei Du,Kai Chen,Jie Xiang,Junbiao Hang,Gang Chen,Hecheng Li
DOI: https://doi.org/10.1002/cam4.70039
IF: 4.711
2024-07-26
Cancer Medicine
Abstract:Background The presence of lymph node (LN) metastasis directly affects the treatment strategy for lung adenocarcinoma (LUAD). Next‐generation sequencing (NGS) has been widely used in patients with advanced LUAD to identify targeted genes, while early detection of pathologic LN metastasis using NGS has not been assessed. Methods Clinicopathologic features and molecular characteristics of 224 patients from Ruijin Hospital were analyzed to detect factors associated with LN metastases. Another 140 patients from Huashan Hospital were set as a test cohort. Results Twenty‐four out of 224 patients were found to have lymph node metastases (10.7%). Pathologic LN‐positive tumors showed higher mutant allele tumor heterogeneity (p
oncology
What problem does this paper attempt to address?